Related Experiment Video
Updated: Jul 12, 2025

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission
Kusuma Chaiyasoot1,2,3, Naomi S Sakai4, Roxanna Zakeri1
1Department of Medicine, Centre for Obesity Research, University College London, London, UK.
Purpose:
Remission of type 2 diabetes (T2D) can be achieved by many, but not all, people following bariatric/metabolic surgery. The mechanisms underlying T2D remission remain incompletely understood. This observational study aimed to identify novel weight-loss independent clinical, metabolic and genetic factors that associate with T2D remission using comprehensive phenotyping.
Materials And Methods:
Ten patients without T2D remission (non-remitters) were matched to 10 patients with T2D remission (remitters) for age, sex, type of surgery, body weight, BMI, post-operative weight loss, duration from surgery and duration of T2D. Detailed body composition assessed using magnetic resonance imaging, gut hormones, serum metabolomics, insulin sensitivity, and genetic risk scores for T2D and anthropometric traits were assessed.
Results:
Remitters had significantly greater β-cell function and circulating acyl ghrelin levels, but lower visceral adipose tissue (VAT): subcutaneous adipose tissue (SAT) ratio than non-remitters. Branched-chain amino acids (BCAAs) and VLDL particle size were the most discriminant metabolites between groups. A significant positive correlation between, VAT area, VAT:SAT ratio and circulating levels of BCAAs was observed, whereas a significant negative correlation between BCAAs and β-cell function was revealed.
Conclusion:
We highlight a potentially novel relationship between VAT and BCAAs, which may play a role in glucoregulatory control. Improvement in β-cell function, and the role ghrelin plays in its recovery, is likely another key factor influencing T2D remission post-surgery. These findings suggest that adjunctive approaches that target VAT loss and restoration of BCAA metabolism might achieve higher rates of long-term T2D remission post-surgery.
Insights
Type 2 diabetes remission after bariatric surgery is linked to improved beta-cell function and acyl ghrelin levels. Targeting visceral adipose tissue and branched-chain amino acid metabolism may enhance remission rates.
Area of Science:
- Metabolic surgery research
- Diabetes remission mechanisms
- Obesity and metabolic health
Background:
- Bariatric surgery effectively treats type 2 diabetes (T2D) in many patients, but remission mechanisms are not fully understood.
- Identifying factors beyond weight loss is crucial for optimizing T2D remission strategies.
- This study investigates clinical, metabolic, and genetic predictors of T2D remission post-surgery.
Purpose of the Study:
- To identify weight-loss independent factors associated with type 2 diabetes remission after bariatric surgery.
- To explore novel clinical, metabolic, and genetic associations with T2D remission.
- To comprehensively phenotype patients who achieved T2D remission versus those who did not.
Main Methods:
- Matched observational study comparing 10 T2D remitters and 10 non-remitters.
- Detailed phenotyping including body composition (MRI), gut hormones, metabolomics, and insulin sensitivity.
- Assessment of genetic risk scores for T2D and anthropometric traits.
Main Results:
- Remitters exhibited enhanced beta-cell function and higher circulating acyl ghrelin levels.
- Lower visceral adipose tissue (VAT) to subcutaneous adipose tissue (SAT) ratio was observed in remitters.
- Branched-chain amino acids (BCAAs) and VLDL particle size were key discriminant metabolites; BCAAs correlated positively with VAT and negatively with beta-cell function.
Conclusions:
- A novel relationship between VAT and BCAAs may influence glucoregulatory control.
- Improved beta-cell function and ghrelin's role are key to T2D remission post-surgery.
- Targeting VAT reduction and BCAA metabolism could improve long-term T2D remission rates.
Related Concept Videos
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...

